2019), in their review of antioxidant interventions in animal models of ASD, reported that these strategies frequently reduce oxidative stress and improve certain behavioral parameters, although many of these effects appear to depend on the continuous administration of the treatment
These include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Use our stack calculator to compare options
FDA Guidance
Vin ung h tr bo v v nui dng ln da trng sng, khe mnh t su bn trong, gim thm nm, tn nhang v bo v da khi tc hi ca tia UV